Brain-Computer Interface Device Makers Must Consider Accessibility And Deployability

24 Nov 2014

Brain-computer interface device makers should consider customer accessibility and clinicians’ ability to deploy the BCI system to get to market, Medtronic technology director says at an FDA meeting. New brain-machine interface include products to help paraplegics walk and people with tremors to grasp tools used in daily life.

Makers of brain-computer interface (BCI) devices designed for amputees and the paralyzed must consider more than customers’ unmet needs, Tim Denison, Medtronic’s senior director of core technology, neuromodulation division, said at a Nov. 21 FDA workshop. (See Also see "FDA Seeks Feedback On Brain-Computer Interface Devices For Amputees" - Medtech Insight, 18 August, 2014..)

Device makers also have to think about the accessibility of the final product to consumers, and burdens on the clinician...